1 active not recruiting, 1 completed, 1 not yet recruiting. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Factor VIII (FVIII): new trials by email Literature Review of Factor VIII (FVIII) trials Research Report on Factor VIII (FVIII)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA Factor VIII (FVIII), Von Willebrand factor (VWF) antigen, VWF:RCo - TTP - Thrombotic Thrombocytopenic Purpura | Not applicable | Active not recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 79 | 2026-02-28 | 2026-06-09 |
| Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients Emicizumab Injection, Factor VIII (FVIII) - Hemophilia A | Phase 2 / Phase 3 | Not yet recruiting | Dhaka Medical College | 20 | 2025-06-01 | 2025-04-22 |
| A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Emicizumab, Factor VIII (FVIII) - Hemophilia A | Phase 3 | Completed | Hoffmann-La Roche | 152 | 2016-09-27 | 2022-11-16 |
Hemophilia A (2) · Purpura, Thrombotic Thrombocytopenic (1)
Dhaka Medical College (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Hoffmann-La Roche (1)
Italy (2) · Australia (1) · Bangladesh (1) · Costa Rica (1) · France (1) · Germany (1) · Ireland (1) · Japan (1) · Poland (1) · South Africa (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Akhil R. Biswas, MBBS, FCPS (1)
PMID 29296836, PMID 30157389, PMID 31697801, PMID 35905294, PMID 35939785, PMID 38853005
2016 (1)